Reference
Huhn K, et al. Alemtuzumab as rescue therapy in a cohort of 50 relapsing-remitting MS patients with breakthrough disease on fingolimod: a multi-center observational study. Journal of Neurology 265: 1521-1527, No. 7, Jul 2018. Available from: URL: http://doi.org/10.1007/s00415-018-8871-2 - Germany
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1712, 37 (2018). https://doi.org/10.1007/s40278-018-49326-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-49326-7